Back

Prognostic relevance of right ventricle global longitudinal strain in heart failure with preserved ejection fraction.

26 May 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Moderated Poster session 1 - Diagnosis and biomarkers Heart Failure with Preserved Ejection Fraction (HFpEF) HFA Premium Access Heart Failure 2018

About the speaker

Photo
Doctor Clotilde Roy

Jolimont Lobbes Hospital, La Louviere (Belgium)

8 More presentations in this session

Presentation thumbnail
Pulsatile hemodynamics in heart failure with reduced ejection fraction - role of forward wave amplitude
Associate Professor T. Weber (Wels, AT)
Abstract Slides
Presentation thumbnail
The opioid system and pathophysiology of heart failure and renal dysfunction
Ms L. Emmens (Groningen, NL)
Abstract Slides
Presentation thumbnail
Norton admission scale as a prognostic factor among acute heart failure patients
Doctor I. Mazin (Ramat Gan, IL)
Abstract Slides
Presentation thumbnail
Baseline B-type natriuretic peptide is the strongest predictor of transition to stage C heart failure in an at-risk population; Results from the STOP-HF prevention programme
Professor K. McDonald (Dublin, IE)
Abstract
Presentation thumbnail
Echocardiographic Killip Classification
Doctor A. Milwidsky (Tel Aviv, IL)
Abstract Slides

Access the full session

Session thumbnail
Moderated Poster session 1 - Diagnosis and biomarkers

The Event

Event poster

Heart Failure 2018

26 May - 29 May 2018
You may be interested in
thumbnail
Congress Presentation
Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: a phenomics approach.
thumbnail
Congress Presentation
Pharmacotherapy in HFpEF: where do cardiometabolic drugs fit in?
thumbnail
Congress Session
Clinical phenotypes of heart failure with preserved ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources